Inpatient Hyperglycemia Management and COVID-19

Link to article at PubMed

Diabetes Ther. 2020 Dec 5:1-12. doi: 10.1007/s13300-020-00966-z. Online ahead of print.


Diabetes is one of the most common comorbidities in hospitalized patients with coronavirus disease 2019 (COVID-19). Inpatient hyperglycemia during this pandemic has been associated with worse outcomes, so it is mandatory to implement effective glycemic control treatment approaches for inpatients with COVID-19. The shortage of personal protective equipment, the need to prevent staff exposure, or the fact that many of the healthcare professionals might be relatively unfamiliar with the management of hyperglycemia may lead to worse glycemic control and, consequently, a worse prognosis. In order to reduce these barriers, we intend to adapt established recommendations to manage hyperglycemia during this pandemic in critical and noncritical care settings.

PMID:33278017 | PMC:PMC7718834 | DOI:10.1007/s13300-020-00966-z

Leave a Reply

Your email address will not be published. Required fields are marked *